Daniel Arias
Stock Analyst at Stifel
(5.00)
# 2
Out of 5,072 analysts
161
Total ratings
61.96%
Success rate
149.12%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Initiates: Buy | $145 | $112.33 | +29.08% | 1 | Dec 1, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,477.56 | +8.29% | 8 | Nov 10, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $67 → $80 | $101.30 | -21.03% | 7 | Nov 4, 2025 | |
| GH Guardant Health | Maintains: Buy | $60 → $70 | $106.60 | -34.33% | 4 | Sep 25, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $48.15 | -16.93% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $11.78 | +1.87% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $103.92 | +5.85% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $64.65 | -7.19% | 11 | May 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $590.76 | +4.95% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $226.00 | +15.04% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.68 | +437.31% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $18.21 | -1.15% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $6.07 | -1.15% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $75.76 | -14.20% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $402.09 | -10.47% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $151.40 | -0.26% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $47.79 | -3.01% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.33 | +200.75% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $168.25 | +23.03% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $130.02 | +53.82% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $1.72 | +191.55% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $3.06 | +226.80% | 2 | May 31, 2022 |
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $112.33
Upside: +29.08%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,477.56
Upside: +8.29%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $67 → $80
Current: $101.30
Upside: -21.03%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $70
Current: $106.60
Upside: -34.33%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $48.15
Upside: -16.93%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $11.78
Upside: +1.87%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $103.92
Upside: +5.85%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $64.65
Upside: -7.19%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $590.76
Upside: +4.95%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $226.00
Upside: +15.04%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.68
Upside: +437.31%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $18.21
Upside: -1.15%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.07
Upside: -1.15%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $75.76
Upside: -14.20%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $402.09
Upside: -10.47%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $151.40
Upside: -0.26%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $47.79
Upside: -3.01%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.33
Upside: +200.75%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $168.25
Upside: +23.03%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $130.02
Upside: +53.82%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $1.72
Upside: +191.55%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $3.06
Upside: +226.80%